申请人:Yasuma Tsuneo
公开号:US20080269220A1
公开(公告)日:2008-10-30
A compound represented by the formula (1):
wherein each symbol is as defined in the specification, and a salt thereof and a prodrug thereof unexpectedly have superior GPR40 receptor agonist activity, superior in the properties as a pharmaceutical product such as stability and the like, and can be a safe and useful pharmaceutical agent as a drug for the prophylaxis or treatment of GPR40 receptor related pathology or diseases such as diabetes and the like.
化合物的化学式为(1):其中每个符号如规范所定义,其盐和前药意外地具有更优越的GPR40受体激动剂活性,在药品产品的稳定性等方面具有优越性,并且可以作为安全有效的药物用于预防或治疗GPR40受体相关的病理或疾病,例如糖尿病等。